[Pathogenetic therapy in newborn from mothers with autoimmune disorders and mixed urogenital infections].
Antipova
I I
II
Moscow Region Research Institute of Obstetrics and Gynecology.
Budykina
T S
TS
Tareeva
T G
TG
Aksenov
A N
AN
Bashakin
N F
NF
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000150:complications* / Q000276:immunology; D001803:Blood Transfusion; D002493:Central Nervous System Diseases / Q000151:congenital / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D005260:Female; D052776:Female Urogenital Diseases / Q000150:complications* / Q000276:immunology; D006401:Hematologic Agents / Q000627:therapeutic use; D006801:Humans; D007124:Immunoenzyme Techniques; D007136:Immunoglobulins / Q000627:therapeutic use; D007231:Infant, Newborn; D007239:Infections / Q000276:immunology / Q000473:pathology / Q000628:therapy* / Q000635:transmission; D018445:Infectious Disease Transmission, Vertical; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000276:immunology*
D000276:Adjuvants, Immunologic; D006401:Hematologic Agents; D007136:Immunoglobulins
Patogeneticheskaia terapiia novorozhdennykh pri autoimmunnykh narusheniiakh u matereĭ so smeshannoĭ urogenital'noĭ infektsieĭ.